11.64
Schlusskurs vom Vortag:
$11.63
Offen:
$11.63
24-Stunden-Volumen:
77,190
Relative Volume:
0.59
Marktkapitalisierung:
$96.98M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Company Profile
Firmenname
Retension Pharmaceuticals, Inc. Common Stock
Sektor
Branche
Telefon
-
Adresse
-
Compare RTSN vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
RTSN
Retension Pharmaceuticals, Inc. Common Stock
|
11.64 | 96.98M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
Retension Pharmaceuticals, Inc. Common Stock Aktie (RTSN) Neueste Nachrichten
With 402,577 common shares, Retension Pharmaceuticals (RTSN) CEO also holds options priced from $1.43. - Stock Titan
CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan
A director buys at $12 a share and converts preferred stock at Retension Pharmaceuticals (RTSN). - Stock Titan
Director Pavan Cheruvu receives 5,636 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan
Total common shares outstanding of RETENSION PHARMACEUTICALS INC – NASDAQ:RTSN - TradingView
Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest press releases and corporate news - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) valuation measures and financial statistics - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) analyst ratings, estimates and forecasts - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) cash flow - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock historical prices and data - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) company profile and facts - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) options chain - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
RTSN Interactive Stock Chart | Retension Pharmaceuticals, Inc. Common Stock Stock - Yahoo Finance
Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Ratings, Estimates & ForecastsYahoo Finance - Yahoo! Finance Canada
Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest stock news and headlines - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) interactive stock chart - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock major holders - Yahoo Finance UK
Retension Pharmaceuticals Announces Pricing of Initial Public Offering - Yahoo! Finance Canada
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock price, news, quote and history - Yahoo Finance UK
Finanzdaten der Retension Pharmaceuticals, Inc. Common Stock-Aktie (RTSN)
Es liegen keine Finanzdaten für Retension Pharmaceuticals, Inc. Common Stock (RTSN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Retension Pharmaceuticals, Inc. Common Stock-Aktie (RTSN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Oct 13 '26 |
Buy |
12.00 |
10,000 |
120,000 |
10,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):